 |
|
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Soon Sun Kim, Jae Youn Cheong
Clin Mol Hepatol. 2022;28(4):802-805. Published online 2022 Sep 14 DOI: https://doi.org/10.3350/cmh.2022.0249
|
|
Citations to this article as recorded by
 Non-linear association of the metabolic score for insulin resistance with obstructive sleep apnea: a cross-sectional study from NHANES 2015–2018
Zhimao Cai, Jiachen Li, Hui Peng, Ye Ye, Sixia Chen, Lingli Zeng, Jiashuang Lin, Weifeng Chen
Frontiers in Nutrition.2025;[Epub] CrossRef Association between METS-IR and heart failure: a cross-sectional study
Xiaozhou Su, Chunli Zhao, Xianwei Zhang
Frontiers in Endocrinology.2024;[Epub] CrossRef Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians
Margeyi Mehta, Jigish Shah, Urvish Joshi
Cureus.2024;[Epub] CrossRef Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 185. CrossRef Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Hye Won Lee
Clinical and Molecular Hepatology.2023; 29(1): 169. CrossRef
|